• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

17例Canavan病患者天冬氨酸酰基转移酶基因突变检测:非犹太人群中的4种新突变

Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.

作者信息

Sistermans E A, de Coo R F, van Beerendonk H M, Poll-The B T, Kleijer W J, van Oost B A

机构信息

Department of Human Genetics, University Hospital, Nijmegen, The Netherlands.

出版信息

Eur J Hum Genet. 2000 Jul;8(7):557-60. doi: 10.1038/sj.ejhg.5200477.

DOI:10.1038/sj.ejhg.5200477
PMID:10909858
Abstract

Canavan disease is a severe progressive autosomal recessive disorder, which is characterised by spongy degeneration of the brain. The disease is caused by mutations in the aspartoacylase gene. Two different mutations were reported on 98% of the alleles of Ashkenazi Jewish patients, in which population the disease is highly prevalent. In non-Jewish patients of European origin, one mutation (914C > A) is found in 50% of the alleles, the other alleles representing all kinds of different mutations. We here describe the results of the mutation analysis in 17 European, non-Jewish patients. Ten different mutations were found, of which four had not been described before (H21P, A57T, R168H, P181T). A deletion of exon4, which until now had only been described once, was revealed in all five alleles of Turkish origin tested, indicating that this is a founder effect in the Turkish population.

摘要

卡纳万病是一种严重的进行性常染色体隐性疾病,其特征为大脑海绵状变性。该疾病由天冬氨酸酰基转移酶基因突变引起。在阿什肯纳兹犹太患者98%的等位基因上报道了两种不同的突变,在该人群中这种疾病非常普遍。在欧洲裔非犹太患者中,50%的等位基因发现一种突变(914C>A),其他等位基因代表各种不同的突变。我们在此描述了17名欧洲裔非犹太患者的突变分析结果。发现了十种不同的突变,其中四种以前未被描述过(H21P、A57T、R168H、P181T)。在所检测的所有五个土耳其裔等位基因中均发现外显子4缺失,此前该缺失仅被描述过一次,表明这是土耳其人群中的一种奠基者效应。

相似文献

1
Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.17例Canavan病患者天冬氨酸酰基转移酶基因突变检测:非犹太人群中的4种新突变
Eur J Hum Genet. 2000 Jul;8(7):557-60. doi: 10.1038/sj.ejhg.5200477.
2
Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.一名患有卡纳万病的土耳其患者中天冬氨酸酰基转移酶基因的新突变。
J Trop Pediatr. 2008 Jun;54(3):208-10. doi: 10.1093/tropej/fmm099. Epub 2007 Nov 12.
3
Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.一名患有卡纳万病的土耳其患者天冬氨酸酰基转移酶基因的新型剪接位点突变
Eur J Paediatr Neurol. 2000;4(1):27-30. doi: 10.1053/ejpn.1999.0256.
4
Canavan disease: diagnosis and molecular analysis.卡纳万病:诊断与分子分析
Genet Test. 1997;1(1):21-5. doi: 10.1089/gte.1997.1.21.
5
Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.非犹太裔卡纳万病患者中八个新突变的鉴定与表达
Am J Hum Genet. 1996 Jul;59(1):95-102.
6
Canavan disease: a novel mutation.Canavan 病:一种新的突变。
Pediatr Neurol. 2011 Oct;45(4):256-8. doi: 10.1016/j.pediatrneurol.2011.06.011.
7
Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.人天冬氨酸酰基转移酶cDNA的克隆及Canavan病中的一个常见错义突变
Nat Genet. 1993 Oct;5(2):118-23. doi: 10.1038/ng1093-118.
8
Canavan disease: mutations among Jewish and non-Jewish patients.卡纳万病:犹太患者和非犹太患者中的突变情况。
Am J Hum Genet. 1994 Jul;55(1):34-41.
9
Frequency of a DNA polymorphism at position Y231 in the aspartoacylase gene and its impact on DNA-based carrier testing for Canavan disease in the Ashkenazi Jewish Population.天冬氨酸酰基转移酶基因中Y231位点DNA多态性的频率及其对阿什肯纳兹犹太人群中基于DNA的卡纳万病携带者检测的影响。
Hum Mutat. 1998;Suppl 1:S161-2. doi: 10.1002/humu.1380110154.
10
Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.非犹太裔卡纳万病患者中天冬氨酸酰基转移酶基因新突变的鉴定与特征分析。
J Inherit Metab Dis. 2002 Nov;25(7):557-70. doi: 10.1023/a:1022091223498.

引用本文的文献

1
Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS/MS neonatal screening method for the diagnosis of Canavan disease.干血斑中 N-乙酰-L-天冬氨酸的定量:一种用于诊断黏多糖贮积症 IV 型的简单、快速的 LC-MS/MS 新生儿筛查方法。
Mol Genet Metab. 2024 Jun;142(2):108489. doi: 10.1016/j.ymgme.2024.108489. Epub 2024 May 3.
2
Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.天冬氨酸酰基转移酶的细胞和分子机制及其在卡纳万病中的作用。
Cell Biosci. 2024 Apr 6;14(1):45. doi: 10.1186/s13578-024-01224-6.
3
A Novel Mutation in Aspartoacylase Gene; Canavan Disease.
天冬氨酸酰基转移酶基因的一种新型突变;卡纳万病
Iran J Child Neurol. 2015 Fall;9(4):54-7.
4
The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients.卡纳万病的临床特征与诊断:一组伊朗患者病例系列
Iran J Child Neurol. 2014 Fall;8(4):66-71.
5
A missense mutation (p.G274R) in gene ASPA causes Canavan disease in a Pakistani family.一个错义突变(p.G274R)在 ASPA 基因中导致一个巴基斯坦家族的 Canavan 病。
Mol Biol Rep. 2012 May;39(5):6197-201. doi: 10.1007/s11033-011-1438-2. Epub 2012 Jan 5.
6
Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease.天冬氨酸酶的修饰,以期用于治疗 Canavan 病的酶替代疗法。
Mol Genet Metab. 2011 Feb;102(2):176-80. doi: 10.1016/j.ymgme.2010.10.012. Epub 2010 Oct 30.
7
Mutational analysis of aspartoacylase: implications for Canavan disease.天冬氨酸酰基转移酶的突变分析:对卡纳万病的意义。
Brain Res. 2007 May 7;1148:1-14. doi: 10.1016/j.brainres.2007.02.069. Epub 2007 Mar 3.
8
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.中枢神经系统中的N-乙酰天门冬氨酸:从神经诊断学走向神经生物学。
Prog Neurobiol. 2007 Feb;81(2):89-131. doi: 10.1016/j.pneurobio.2006.12.003. Epub 2007 Jan 5.
9
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease.天冬氨酸酰基转移酶的结构,该脑酶在卡纳万病中受损。
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. doi: 10.1073/pnas.0607817104. Epub 2006 Dec 28.
10
Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.非犹太裔卡纳万病患者中天冬氨酸酰基转移酶基因新突变的鉴定与特征分析。
J Inherit Metab Dis. 2002 Nov;25(7):557-70. doi: 10.1023/a:1022091223498.